To examine why intratumoral PD-L1 mRNA expression did not entirely predict the antitumor activity of the anti-PD-L1 mAb in the mouse models, we analyzed the mechanism of action of the anti-PD-L1 mAb in a low-PD-L1 tumor model. This evidence concerns the gene CD274 and neoplasm.